Logo image of IR

INGERSOLL-RAND INC (IR) Stock Fundamental Analysis

NYSE:IR - New York Stock Exchange, Inc. - US45687V1061 - Common Stock - Currency: USD

86.98  +0.43 (+0.5%)

After market: 86.98 0 (0%)

Fundamental Rating

5

Overall IR gets a fundamental rating of 5 out of 10. We evaluated IR against 128 industry peers in the Machinery industry. IR scores excellent on profitability, but there are some minor concerns on its financial health. IR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IR was profitable.
IR had a positive operating cash flow in the past year.
Of the past 5 years IR 4 years were profitable.
In the past 5 years IR always reported a positive cash flow from operatings.
IR Yearly Net Income VS EBIT VS OCF VS FCFIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.48%, IR is in line with its industry, outperforming 48.44% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.85%, IR is in line with its industry, outperforming 46.09% of the companies in the same industry.
IR has a Return On Invested Capital of 6.78%. This is comparable to the rest of the industry: IR outperforms 47.66% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IR is below the industry average of 10.71%.
The last Return On Invested Capital (6.78%) for IR is above the 3 year average (6.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.48%
ROE 7.85%
ROIC 6.78%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.33%
ROIC(5y)4.79%
IR Yearly ROA, ROE, ROICIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin of IR (11.30%) is better than 79.69% of its industry peers.
In the last couple of years the Profit Margin of IR has grown nicely.
The Operating Margin of IR (20.07%) is better than 89.06% of its industry peers.
IR's Operating Margin has improved in the last couple of years.
IR's Gross Margin of 43.80% is amongst the best of the industry. IR outperforms 80.47% of its industry peers.
In the last couple of years the Gross Margin of IR has grown nicely.
Industry RankSector Rank
OM 20.07%
PM (TTM) 11.3%
GM 43.8%
OM growth 3Y18.5%
OM growth 5Y9.27%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
IR Yearly Profit, Operating, Gross MarginsIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

6

2. Health

2.1 Basic Checks

IR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IR remains at a similar level compared to 1 year ago.
IR has more shares outstanding than it did 5 years ago.
IR has a worse debt/assets ratio than last year.
IR Yearly Shares OutstandingIR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
IR Yearly Total Debt VS Total AssetsIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 3.69 indicates that IR is not in any danger for bankruptcy at the moment.
IR's Altman-Z score of 3.69 is fine compared to the rest of the industry. IR outperforms 61.72% of its industry peers.
IR has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as IR would need 3.48 years to pay back of all of its debts.
IR has a better Debt to FCF ratio (3.48) than 62.50% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that IR is not too dependend on debt financing.
IR has a Debt to Equity ratio (0.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 3.48
Altman-Z 3.69
ROIC/WACC0.7
WACC9.75%
IR Yearly LT Debt VS Equity VS FCFIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

IR has a Current Ratio of 2.38. This indicates that IR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IR (2.38) is better than 60.16% of its industry peers.
IR has a Quick Ratio of 1.76. This is a normal value and indicates that IR is financially healthy and should not expect problems in meeting its short term obligations.
IR has a better Quick ratio (1.76) than 73.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.76
IR Yearly Current Assets VS Current LiabilitesIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

IR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.53%.
IR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.65% yearly.
IR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.27%.
IR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.10% yearly.
EPS 1Y (TTM)4.53%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-7.69%
Revenue 1Y (TTM)5.27%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%2.8%

3.2 Future

Based on estimates for the next years, IR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.55% on average per year.
Based on estimates for the next years, IR will show a small growth in Revenue. The Revenue will grow by 8.00% on average per year.
EPS Next Y4.86%
EPS Next 2Y7.23%
EPS Next 3Y8.1%
EPS Next 5Y12.55%
Revenue Next Year3.54%
Revenue Next 2Y4.19%
Revenue Next 3Y4.64%
Revenue Next 5Y8%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IR Yearly Revenue VS EstimatesIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
IR Yearly EPS VS EstimatesIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.93, the valuation of IR can be described as expensive.
IR's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of IR to the average of the S&P500 Index (27.45), we can say IR is valued inline with the index average.
The Price/Forward Earnings ratio is 22.99, which indicates a rather expensive current valuation of IR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of IR to the average of the S&P500 Index (21.90), we can say IR is valued inline with the index average.
Industry RankSector Rank
PE 26.93
Fwd PE 22.99
IR Price Earnings VS Forward Price EarningsIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IR is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
IR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 25.6
EV/EBITDA 19.66
IR Per share dataIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IR does not grow enough to justify the current Price/Earnings ratio.
IR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.54
PEG (5Y)1.72
EPS Next 2Y7.23%
EPS Next 3Y8.1%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.09%, IR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.87, IR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, IR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.09%

5.2 History

IR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IR Yearly Dividends per shareIR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

3.93% of the earnings are spent on dividend by IR. This is a low number and sustainable payout ratio.
DP3.93%
EPS Next 2Y7.23%
EPS Next 3Y8.1%
IR Yearly Income VS Free CF VS DividendIR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
IR Dividend Payout.IR Dividend Payout, showing the Payout Ratio.IR Dividend Payout.PayoutRetained Earnings

INGERSOLL-RAND INC

NYSE:IR (7/3/2025, 7:38:22 PM)

After market: 86.98 0 (0%)

86.98

+0.43 (+0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners99.82%
Inst Owner Change-0.24%
Ins Owners0.17%
Ins Owner Change7.79%
Market Cap35.09B
Analysts77.6
Price Target91.41 (5.09%)
Short Float %3.01%
Short Ratio4.03
Dividend
Industry RankSector Rank
Dividend Yield 0.09%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP3.93%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-15 2025-05-15 (0.02)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.98%
Min EPS beat(2)-4.75%
Max EPS beat(2)-3.21%
EPS beat(4)2
Avg EPS beat(4)-1.17%
Min EPS beat(4)-4.75%
Max EPS beat(4)3.04%
EPS beat(8)6
Avg EPS beat(8)4.06%
EPS beat(12)10
Avg EPS beat(12)5.65%
EPS beat(16)14
Avg EPS beat(16)6.75%
Revenue beat(2)0
Avg Revenue beat(2)-3.39%
Min Revenue beat(2)-3.44%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.26%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)-2.68%
Revenue beat(8)2
Avg Revenue beat(8)-1.82%
Revenue beat(12)6
Avg Revenue beat(12)-0.28%
Revenue beat(16)9
Avg Revenue beat(16)-0.14%
PT rev (1m)-0.63%
PT rev (3m)-10.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.32%
EPS NY rev (1m)0.13%
EPS NY rev (3m)-2.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 26.93
Fwd PE 22.99
P/S 4.82
P/FCF 25.6
P/OCF 23.53
P/B 3.35
P/tB N/A
EV/EBITDA 19.66
EPS(TTM)3.23
EY3.71%
EPS(NY)3.78
Fwd EY4.35%
FCF(TTM)3.4
FCFY3.91%
OCF(TTM)3.7
OCFY4.25%
SpS18.05
BVpS25.99
TBVpS-5.49
PEG (NY)5.54
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 4.48%
ROE 7.85%
ROCE 8.83%
ROIC 6.78%
ROICexc 7.51%
ROICexgc 50.08%
OM 20.07%
PM (TTM) 11.3%
GM 43.8%
FCFM 18.83%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.33%
ROIC(5y)4.79%
ROICexc(3y)7.12%
ROICexc(5y)5.43%
ROICexgc(3y)46.29%
ROICexgc(5y)35.83%
ROCE(3y)8.25%
ROCE(5y)6.23%
ROICexcg growth 3Y22.68%
ROICexcg growth 5Y21.38%
ROICexc growth 3Y22.68%
ROICexc growth 5Y6.23%
OM growth 3Y18.5%
OM growth 5Y9.27%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 3.48
Debt/EBITDA 2.45
Cap/Depr 24.86%
Cap/Sales 1.65%
Interest Coverage 7.94
Cash Conversion 76.64%
Profit Quality 166.61%
Current Ratio 2.38
Quick Ratio 1.76
Altman-Z 3.69
F-Score6
WACC9.75%
ROIC/WACC0.7
Cap/Depr(3y)25.25%
Cap/Depr(5y)20.22%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.5%
Profit Quality(3y)146.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-7.69%
EPS Next Y4.86%
EPS Next 2Y7.23%
EPS Next 3Y8.1%
EPS Next 5Y12.55%
Revenue 1Y (TTM)5.27%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%2.8%
Revenue Next Year3.54%
Revenue Next 2Y4.19%
Revenue Next 3Y4.64%
Revenue Next 5Y8%
EBIT growth 1Y12.43%
EBIT growth 3Y32.7%
EBIT growth 5Y41.07%
EBIT Next Year17.91%
EBIT Next 3Y10.73%
EBIT Next 5Y12.23%
FCF growth 1Y54.83%
FCF growth 3Y31.28%
FCF growth 5Y32.51%
OCF growth 1Y51.48%
OCF growth 3Y31.41%
OCF growth 5Y32.4%